General Information of the Compound
Compound ID |
CP0400592
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-(2-allylphenoxy)-3-morpholinopropan-2-ol
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(2-Allyl-phenoxy)-3-morpholin-4-yl-propan-2-ol
1-(2-allylphenoxy)-3-morpholin-4-ylpropan-2-ol
1-(2-allylphenoxy)-3-morpholinopropan-2-ol
1-morpholin-4-yl-3-(2-prop-2-enylphenoxy)propan-2-ol
AC1MCHI5
AKOS000525780
AKOS016050431
BAS 00134198
BDBM50318978
CHEMBL1083667
EN300-241692
HMS2803P24
MCULE-7265762065
MLS001143833
MolPort-001-916-053
Oprea1_634560
Oprea1_670642
SMR000473272
ST50000343
STK843731
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H23NO3
|
||||||||||||||||||
Molecular Weight |
277.364
|
||||||||||||||||||
Canonical SMILES |
OC(COc1ccccc1CC=C)CN1CCOCC1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H23NO3/c1-2-5-14-6-3-4-7-16(14)20-13-15(18)12-17-8-10-19-11-9-17/h2-4,6-7,15,18H,1,5,8-13H2
Show/Hide
|
||||||||||||||||||
InChIKey |
BKDPODVOOWQEGE-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor
Protein ID: PT06109, Geminin
Clinical Information about the Compound